Systemic sclerosis-associated interstitial lung disease: Role of the oesophagus in outcomes

被引：3
|
作者：
Strek, Mary E. [1 ]
机构：
[1] Univ Chicago, Med Ctr, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA
来源：
RESPIROLOGY | 2018年 / 23卷 / 10期
关键词：
oesophageal disease; hiatal hernia; interstitial lung disease; systemic sclerosis; IDIOPATHIC PULMONARY-FIBROSIS; GASTROESOPHAGEAL-REFLUX; MANAGEMENT;
D O I：
10.1111/resp.13335
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：885 / 886
页数：2
相关论文
共 50 条
  • [21] Current treatment of systemic sclerosis-associated interstitial lung disease
    Bes, Cemal
    Cetinkaya, Erdogan
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2022, 70 (01): : 85 - 92
  • [22] Responses to exercise in systemic sclerosis-associated interstitial lung disease
    Donnelly, Ronan P.
    Smyth, Anita E.
    Mullan, Charles
    Riley, Marshall S.
    Nicholls, D. Paul
    CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2023, 43 (04) : 253 - 262
  • [23] Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
    Yamasaki, Yoshioki
    Kuwana, Masataka
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (06) : 547 - 560
  • [24] Systemic sclerosis-associated interstitial lung disease treated with tocilizumab
    Dauny, Vincent
    Borie, Raphael
    Forien, Marine
    Ghanem, Mada
    Palazzo, Elisabeth
    Jelin, Germain
    Dieude, Philippe
    Ottaviani, Sebastien
    INTERNAL MEDICINE JOURNAL, 2021, 51 (06) : 999 - 1000
  • [25] Management of Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: A Focus on the Role of the Pharmacist
    Farrell, Jessica
    Ho, Lawrence
    INTEGRATED PHARMACY RESEARCH AND PRACTICE, 2023, 12 : 101 - 112
  • [26] Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
    Rahaghi, Franck F.
    Hsu, Vivien M.
    Kaner, Robert J.
    Mayes, Maureen D.
    Rosas, Ivan O.
    Saggar, Rajan
    Steen, Virginia D.
    Strek, Mary E.
    Bernstein, Elana J.
    Bhatt, Nitin
    Castelino, Flavia V.
    Chung, Lorinda
    Domsic, Robyn T.
    Flaherty, Kevin R.
    Gupta, Nishant
    Kahaleh, Bashar
    Martinez, Fernando J.
    Morrow, Lee E.
    Moua, Teng
    Patel, Nina
    Shlobin, Oksana A.
    Southern, Brian D.
    Volkmann, Elizabeth R.
    Khanna, Dinesh
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [27] Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
    C. Meier
    K. Freiburghaus
    C. Bovet
    J. Schniering
    Y. Allanore
    O. Distler
    C. Nakas
    B. Maurer
    Scientific Reports, 10
  • [28] Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
    Hoffmann-Vold, Anna-Maria
    Allanore, Yannick
    Alves, Margarida
    Brunborg, Cathrine
    Airo, Paolo
    Ananieva, Lidia P.
    Czirjak, Laszlo
    Guiducci, Serena
    Hachulla, Eric
    Li, Mengtao
    Mihai, Carina
    Riemekasten, Gabriela
    Sfikakis, Petros P.
    Kowal-Bielecka, Otylia
    Riccardi, Antonella
    Distler, Oliver
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (02) : 219 - 227
  • [29] Characterization of the Pericyte Transcriptome in Systemic Sclerosis-associated Interstitial Lung Disease
    Wilson, C. L.
    Renaud, L.
    Simon, B.
    Feghali-Bostwick, C.
    Schnapp, L. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [30] Consensus statements for managing systemic sclerosis-associated interstitial lung disease
    Proudman, Susanna
    LANCET RHEUMATOLOGY, 2020, 2 (02): : E64 - E65
12345